Basic Information
| RNALocate ID: | RLID:11003011 |
| RNA Symbol: | hsa-miR-193b-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-193b |
| RNA ID: | miRBase:MIMAT0002819 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002338 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01002339 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002340 | Mitochondrion | Myotube | 27396686 |
| RLID:01002341 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002342 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002343 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002344 | Nucleolus | HeLa cells | 23940654 |
| RLID:01002345 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11003004 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
| RLID:11003005 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003006 | Exosome | Brain tissue | 23382797 |
| RLID:11003007 | Exosome | Plasma | 23663360 |
| RLID:11003008 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003009 | Exosome | Plasma | 24683445 |
| RLID:11003010 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11003012 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000154 | Exosome | B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Tongue tissue | |
| RLID-D:11000486 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-193b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-23139 |
| MNDR | hsa-miR-193b-3p | Oral squamous cell carcinoma | MNDR-E-MI-23140 |
| MNDR | hsa-miR-193b-3p | Medulloblastoma | MNDR-E-MI-23141 |
| MNDR | hsa-miR-193b-3p | Lymphoma | MNDR-E-MI-23142 |
| MNDR | hsa-miR-193b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-23143 |
| MNDR | hsa-miR-193b-3p | Dermatomyositis | MNDR-E-MI-23144 |
| MNDR | hsa-miR-193b-3p | Prostate cancer | MNDR-E-MI-23145 |
| MNDR | hsa-miR-193b-3p | Gastric cancer | MNDR-E-MI-23146 |
| MNDR | hsa-miR-193b-3p | Alzheimer disease | MNDR-E-MI-23147 |
| MNDR | hsa-miR-193b-3p | Intracranial aneurysm | MNDR-E-MI-23148 |
| MNDR | hsa-miR-193b-3p | Dysautonomia familial | MNDR-E-MI-23149 |
| MNDR | hsa-miR-193b-3p | Myotonic dystrophy | MNDR-E-MI-23150 |
| MNDR | hsa-miR-193b-3p | Muscular dystrophy duchenne | MNDR-E-MI-23151 |
| MNDR | hsa-miR-193b-3p | Head and neck cancer | MNDR-E-MI-23152 |
| MNDR | hsa-miR-193b-3p | Leukemia | MNDR-E-MI-23153 |
| MNDR | hsa-miR-193b-3p | Huntington disease | MNDR-E-MI-23154 |
| MNDR | hsa-miR-193b-3p | Chorea | MNDR-E-MI-23155 |
| MNDR | hsa-miR-193b-3p | Cardiovascular disease | MNDR-E-MI-23156 |
| MNDR | hsa-miR-193b-3p | Lung cancer | MNDR-E-MI-23157 |
| MNDR | hsa-miR-193b-3p | Fragile x syndrome | MNDR-E-MI-23158 |
| MNDR | hsa-miR-193b-3p | Parkinson disease | MNDR-E-MI-23159 |
| MNDR | hsa-miR-193b-3p | Basal-like breast cancer | MNDR-E-MI-23160 |
| MNDR | hsa-miR-193b-3p | Neuroendocrine neoplasia | MNDR-E-MI-23161 |
| MNDR | hsa-miR-193b-3p | Thyroid cancer | MNDR-E-MI-23162 |
| MNDR | hsa-miR-193b-3p | Pancreatic cancer | MNDR-E-MI-23163 |
| MNDR | hsa-miR-193b-3p | Melanoma | MNDR-E-MI-23164 |
| MNDR | hsa-miR-193b-3p | Rectum adenocarcinoma | MNDR-E-MI-23165 |
| MNDR | hsa-miR-193b-3p | Colon cancer | MNDR-E-MI-23166 |
| MNDR | hsa-miR-193b-3p | Ischemic attack transient | MNDR-E-MI-23167 |
| MNDR | hsa-miR-193b-3p | Colon adenocarcinoma | MNDR-E-MI-23168 |
| MNDR | hsa-miR-193b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-23169 |
| MNDR | hsa-miR-193b-3p | Familial ovarian cancer | MNDR-E-MI-23170 |
| MNDR | hsa-miR-193b-3p | Glioblastoma | MNDR-E-MI-23171 |
| MNDR | hsa-miR-193b-3p | Glioma | MNDR-E-MI-23172 |
| MNDR | hsa-miR-193b-3p | Central nervous system lymphoma | MNDR-E-MI-23173 |
| MNDR | hsa-miR-193b-3p | Chordoma | MNDR-E-MI-23174 |
| MNDR | hsa-miR-193b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-23175 |
| MNDR | hsa-miR-193b-3p | Epilepsy temporal lobe | MNDR-E-MI-23176 |
| MNDR | hsa-miR-193b-3p | Osteosarcoma | MNDR-E-MI-23177 |
| MNDR | hsa-miR-193b-3p | Inclusion body myositis | MNDR-E-MI-23178 |
| MNDR | hsa-miR-193b-3p | Infarction middle cerebral artery | MNDR-E-MI-23179 |
| MNDR | hsa-miR-193b-3p | Meningioma | MNDR-E-MI-23180 |
| MNDR | hsa-miR-193b-3p | Cervical adenocarcinoma | MNDR-E-MI-23181 |
| MNDR | hsa-miR-193b-3p | Gastric adenocarcinoma | MNDR-E-MI-23182 |
| MNDR | hsa-miR-193b-3p | Cervical squamous cell carcinoma | MNDR-E-MI-23183 |
| MNDR | hsa-miR-193b-3p | Lung squamous cell carcinoma | MNDR-E-MI-23184 |
| MNDR | hsa-miR-193b-3p | Non-small cell lung cancer | MNDR-E-MI-23185 |
| MNDR | hsa-miR-193b-3p | Lung adenocarcinoma | MNDR-E-MI-23186 |
| MNDR | hsa-miR-193b-3p | Thyroid carcinoma | MNDR-E-MI-23187 |
| MNDR | hsa-miR-193b-3p | Bladder urothelial carcinoma | MNDR-E-MI-23188 |
| MNDR | hsa-miR-193b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-23189 |
| MNDR | hsa-miR-193b-3p | Brain stem cancer | MNDR-E-MI-23190 |
| MNDR | hsa-miR-193b-3p | Carcinoma renal cell | MNDR-E-MI-23191 |
| MNDR | hsa-miR-193b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-23192 |
| MNDR | hsa-miR-193b-3p | Renal clear cell carcinoma | MNDR-E-MI-23193 |
| MNDR | hsa-miR-193b-3p | Large cell carcinoma | MNDR-E-MI-23194 |
| MNDR | hsa-miR-193b-3p | Biliary tract cancer | MNDR-E-MI-23195 |
| MNDR | hsa-miR-193b-3p | Cholangiocarcinoma | MNDR-E-MI-23196 |
| MNDR | hsa-miR-193b-3p | Esophageal cancer | MNDR-E-MI-23197 |
| MNDR | hsa-miR-193b-3p | Oncocytoma | MNDR-E-MI-23198 |
| MNDR | hsa-miR-193b-3p | Lung small cell carcinoma | MNDR-E-MI-23199 |
| MNDR | hsa-miR-193b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-23200 |
| MNDR | hsa-miR-193b-3p | Uveal melanoma | MNDR-E-MI-23201 |
| MNDR | hsa-miR-193b-3p | Hepatocellular carcinoma | MNDR-E-MI-23202 |
| MNDR | hsa-miR-193b-3p | Familiar ovarian carcinoma | MNDR-E-MI-23203 |
| MNDR | hsa-miR-193b-3p | Chronic kidney disease | MNDR-E-MI-23204 |
| MNDR | hsa-miR-193b-3p | Hodgkin lymphoma | MNDR-E-MI-23205 |
| MNDR | hsa-miR-193b-3p | Burkitt lymphoma | MNDR-E-MI-23206 |
| MNDR | hsa-miR-193b-3p | Skin cutaneous melanoma | MNDR-E-MI-23207 |
| MNDR | hsa-miR-193b-3p | Skin melanoma | MNDR-E-MI-23208 |
| MNDR | hsa-miR-193b-3p | Autosomal dominant polycystic kidney disease | MNDR-E-MI-23209 |
| MNDR | hsa-miR-193b-3p | Acute myeloid leukemia | MNDR-E-MI-23210 |
| MNDR | hsa-miR-193b-3p | Colorectal cancer | MNDR-E-MI-23211 |
| MNDR | hsa-miR-193b-3p | Nasopharynx carcinoma | MNDR-E-MI-23212 |
| MNDR | hsa-miR-193b-3p | Multiple myeloma | MNDR-E-MI-23213 |
| MNDR | hsa-miR-193b-3p | Nasopharyngeal cancer | MNDR-E-MI-23214 |
| MNDR | hsa-miR-193b-3p | Epstein-barr virus infections | MNDR-E-MI-23215 |
| MNDR | hsa-miR-193b-3p | Brain injury chronic | MNDR-E-MI-23216 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACTB | Homo sapiens | RR00036852 |
TOP